Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials

被引：0
|
作者：
Andrew M. Blumenfeld
Kerry Knievel
Aubrey Manack Adams
Lawrence Severt
Matthew Butler
Hongxin Lai
David W. Dodick
机构：
[1] Headache Center of Southern California,
[2] Barrow Neurological Institute,undefined
[3] AbbVie,undefined
[4] AbbVie,undefined
[5] Mayo Clinic,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
Acute treatment; Concomitant therapies; Migraine; Preventive treatment; Ubrogepant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：692 / 705
页数：13
相关论文
共 50 条
  • [1] Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials
    Blumenfeld, Andrew M.
    Knievel, Kerry
    Manack Adams, Aubrey
    Severt, Lawrence
    Butler, Matthew
    Lai, Hongxin
    Dodick, David W.
    ADVANCES IN THERAPY, 2022, 39 (01) : 692 - 705
  • [2] Efficacy and Safety of Ubrogepant in Participants Taking Concomitant Preventive Medication
    Blumenfeld, Andrew M.
    Knievel, Kerry
    Adams, Aubrey Manack
    Severt, Lawrence
    Butler, Matthew
    Lai, Hongxin
    Dodick, David W.
    NEUROLOGY, 2020, 94 (15)
  • [3] EFFICACY AND SAFETY OF UBROGEPANT IN PARTICIPANTS TAKING CONCOMITANT PREVENTIVE MEDICATION
    Blumenfeld, Andrew M.
    Knievel, Kerry
    Adams, Aubrey Manack
    Severt, Lawrence
    Butler, Matthew
    Lai, Hongxin
    Dodick, David W.
    CEPHALALGIA, 2020, 40 : 47 - 48
  • [4] Efficacy and Safety of Ubrogepant in Participants Taking Concomitant Preventive Medication
    Blumenfeld, A. M.
    Knievel, K.
    Adams, Manack A.
    Severt, L.
    Butler, M.
    Lai, H.
    Dodick, D. W.
    HEADACHE, 2020, 60 : 92 - 93
  • [5] Rimegepant is Effective for the Acute Treatment of Migraine in Subjects Taking Concurrent Preventive Medication: Results From 3 Phase 3 Trials
    Pavlovic, Jelena
    Dodick, David
    Newman, Lawrence
    Lipton, Richard
    Stock, Elyse
    Thiry, Alexandra
    Conway, Charles
    Jensen, Christopher
    Morris, Beth
    Coric, Vladimir
    Croop, Robert
    NEUROLOGY, 2020, 94 (15)
  • [6] Rimegepant is Effective for the Acute Treatment of Migraine in Subjects Taking Concurrent Preventive Medication: Results From 3 Phase 3 Trials
    Dodick, D. W.
    Pavlovic, J.
    Newman, L.
    Lipton, R. B.
    Thiry, A. C.
    Morris, B. A.
    Coric, V
    Croop, R.
    HEADACHE, 2019, 59 : 177 - 177
  • [7] Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy From ACHIEVE I and ACHIEVE II Phase 3 Trials
    Hutchinson, S.
    Dodick, D. W.
    Treppendahl, C.
    Bennett, N. L.
    Yu, S.
    Trugman, J. M.
    HEADACHE, 2020, 60 : 93 - 93
  • [8] Rimegepant is Effective for the Acute Treatment of Migraine in Subjects Taking Concurrent Preventive Medication: Results From 3 Phase 3 Trials
    Dodick, David W.
    Pavlovic, Jelena M.
    Newman, Lawrence C.
    Lipton, Richard B.
    Thiry, Alexandra
    Morris, Beth A.
    Coric, Vladimir
    Croop, Robert
    CEPHALALGIA, 2019, 39 : 188 - 189
  • [9] Safety and Tolerability of Ubrogepant for the Acute Treatment of Migraine in Participants Taking Atogepant for the Preventive Treatment of Episodic Migraine: Results from the TANDEM Trial
    Ailani, Jessica
    Lipton, Richard B.
    Blumenfeld, Andrew M.
    He, Molly Yizeng
    Smith, Jonathan H.
    Trugman, Joel M.
    Ferreira, Rosa de Abreu
    Brand-Schieber, Elimor
    CEPHALALGIA, 2023, 43 (1supp)
  • [10] Safety and tolerability of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine: Results from the TANDEM study
    Ailani, Jessica
    Lipton, Richard B.
    Blumenfeld, Andrew M.
    Mechtler, Laszlo
    Klein, Brad C.
    He, Molly Yizeng
    Smith, Jonathan H.
    Trugman, Joel M.
    Ferreira, Rosa de Abreu
    Brand-Schieber, Elimor
    HEADACHE, 2024,
12345